These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 32282345

  • 1. Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas.
    Cracolici V, Ritterhouse LL, Segal JP, Puranik R, Wanjari P, Kadri S, Parilla M, Cipriani NA.
    Am J Surg Pathol; 2020 Jul; 44(7):881-892. PubMed ID: 32282345
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
    Jung CK, Kim Y, Jeon S, Jo K, Lee S, Bae JS.
    Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
    Wang N, Liu T, Sofiadis A, Juhlin CC, Zedenius J, Höög A, Larsson C, Xu D.
    Cancer; 2014 Oct 01; 120(19):2965-79. PubMed ID: 24898513
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine.
    Hysek M, Paulsson JO, Wang N, Jatta K, Lindh C, Fuentes-Martinez N, Shabo I, Zedenius J, Juhlin CC.
    Virchows Arch; 2018 Nov 01; 473(5):639-643. PubMed ID: 29860621
    [Abstract] [Full Text] [Related]

  • 12. Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics.
    Xu B, Tuttle RM, Sabra MM, Ganly I, Ghossein R.
    Thyroid; 2017 May 01; 27(5):632-640. PubMed ID: 28049366
    [Abstract] [Full Text] [Related]

  • 13. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
    Liu T, Wang N, Cao J, Sofiadis A, Dinets A, Zedenius J, Larsson C, Xu D.
    Oncogene; 2014 Oct 16; 33(42):4978-84. PubMed ID: 24141777
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
    Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Carvalheiro M, Máximo V, Sobrinho-Simões M, Soares P.
    J Clin Endocrinol Metab; 2014 May 16; 99(5):E754-65. PubMed ID: 24476079
    [Abstract] [Full Text] [Related]

  • 17. Changes in the clinicopathological characteristics and genetic alterations of follicular thyroid cancer.
    Song YS, Lim JA, Min HS, Kim MJ, Choi HS, Cho SW, Moon JH, Yi KH, Park DJ, Cho BY, Park YJ.
    Eur J Endocrinol; 2017 Dec 16; 177(6):465-473. PubMed ID: 28864536
    [Abstract] [Full Text] [Related]

  • 18. Effect of single-nucleotide polymorphism in TERT promoter on follicular thyroid tumor development.
    Hirokawa T, Arimasu Y, Nakazato Y, Chiba T, Fujiwara M, Kamma H.
    Pathol Int; 2020 Apr 16; 70(4):210-216. PubMed ID: 31943533
    [Abstract] [Full Text] [Related]

  • 19. RAS-Mutant Follicular Thyroid Tumors: A Continuous Challenge for Pathologists.
    Hernandez-Prera JC, Wenig BM.
    Endocr Pathol; 2024 Sep 16; 35(3):167-184. PubMed ID: 38888731
    [Abstract] [Full Text] [Related]

  • 20. DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma.
    Zhang H, Zhang Z, Liu X, Duan H, Xiang T, He Q, Su Z, Wu H, Liang Z.
    J Clin Endocrinol Metab; 2021 Mar 25; 106(4):1011-1021. PubMed ID: 33394038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.